Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
264.8 USD | +2.31% | +0.67% | +10.00% |
Apr. 25 | Willis Towers Watson's Q1 Adjusted Earnings, Revenue Advance; 2024 Earnings, Revenue Outlook Issued | MT |
Apr. 25 | Insurance broker WTW beats profit estimates on strong demand | RE |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's enterprise value to sales, at 3.06 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Sector: Multiline Insurance & Brokers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.00% | 27.05B | - | ||
+5.37% | 51.7B | B- | ||
+15.71% | 23.44B | C | ||
+24.11% | 9.27B | - | ||
+15.81% | 6.03B | - | ||
-3.18% | 4.06B | B | ||
+1.62% | 2.03B | C+ | ||
+10.95% | 1.77B | C- | ||
-29.87% | 1.52B | C- | ||
+13.49% | 1.25B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- WTW Stock
- 0Y4Q Stock
- Ratings Willis Towers Watson Public Limited Company